Changeflow GovPing Government General Virginia Psilocybin Rescheduling Upon FDA Approval
Priority review Rule Added Final

Virginia Psilocybin Rescheduling Upon FDA Approval

Favicon for changeflow.com Virginia Legislative Events
Published
Detected
Email

Summary

Virginia Governor signed SB379, directing the Board of Pharmacy to reschedule psilocybin consistent with federal scheduling upon FDA approval of a psilocybin formulation for healthcare professional administration in clinical settings. The law takes effect July 1, 2026.

What changed

Virginia enacted SB379, which requires the Board of Pharmacy to automatically reschedule psilocybin to align with federal scheduling upon FDA approval of a formulation designed for administration by healthcare professionals in healthcare settings. The bill creates a conditional rescheduling mechanism rather than immediate scheduling.

Healthcare providers and pharmaceutical companies should prepare for future psilocybin rescheduling by monitoring FDA approval proceedings. The Board of Pharmacy must track federal scheduling changes and align Virginia's schedule accordingly, creating an automated compliance pathway once federal approval occurs. Pharmaceutical manufacturers developing psilocybin formulations should engage with regulators to understand approval requirements.

What to do next

  1. Monitor FDA approval process for psilocybin formulations intended for clinical administration
  2. Prepare internal compliance protocols for potential rescheduling
  3. Review state licensing requirements for psilocybin handling in healthcare settings

Archived snapshot

Apr 8, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

ChangeBridge / Virginia / SB379 Signed by Governor SB379 Senate Bill Signed by Governor 2026-04-06

Psilocybin; Board of Pharmacy to reschedule upon federal scheduling changes.

Board of Pharmacy; regulation of psilocybin. Directs the Board of Pharmacy to reschedule psilocybin consistent with federal scheduling upon approval by the U.S. Food and Drug Administration of a formulation of psilocybin designed to be administered by a health care professional in a health care setting. This bill is identical to HB 1347.

Bill Details

State Virginia

Session 2026 Regular Regular Session

Chamber Senate

Official Source lis.virginia.gov/bill-details/20261/SB379

LegiScan View on LegiScan

Sponsors

Jennifer Boysko (Sen - D) Scott Surovell (Sen - D)

Action History

2026-04-06 Approved by Governor-Chapter 306 (effective 7/1/2026) 2026-04-06 Approved by Governor-Chapter 306 (effective 7/1/2026) 2026-03-10 Governor's Action Deadline 11:59 p.m., April 13, 2026 2026-03-10 S Enrolled Bill communicated to Governor on March 10, 2026 2026-02-26 S Signed by President 2026-02-26 H Signed by Speaker 2026-02-26 S Fiscal Impact Statement from Department of Planning and Budget (SB379) 2026-02-26 S Bill text as passed Senate and House (SB379ER) 2026-02-26 S Enrolled 2026-02-24 H Passed House (98-Y 0-N 0-A) 2026-02-24 H Read third time 2026-02-23 H Read second time 2026-02-19 H Reported from Health and Human Services (21-Y 0-N) 2026-02-13 H Referred to Committee on Health and Human Services 2026-02-13 H Read first time 2026-02-13 H Placed on Calendar 2026-02-11 S Fiscal Impact Statement from Department of Planning and Budget (SB379) 2026-02-10 S Read third time and passed Senate (40-Y 0-N 0-A) 2026-02-09 S Engrossed by Senate - committee substitute Block Vote (Voice Vote) 2026-02-09 S Education and Health Substitute agreed to 2026-02-09 S Read second time 2026-02-06 S Passed by for the day 2026-02-06 S Passed by for the day (Voice Vote) 2026-02-06 S Constitutional reading dispensed (on 1st reading) (39-Y 0-N 0-A) 2026-02-06 S Rules suspended 2026-02-06 S Committee substitute printed 26106612D-S1 2026-02-05 S Reported from Education and Health with substitute (14-Y 0-N) 2026-01-30 S Senate subcommittee offered 2026-01-30 S Assigned Education sub: Health Professions 2026-01-29 S Fiscal Impact Statement from Department of Planning and Budget (SB379) 2026-01-13 S Referred to Committee on Education and Health 2026-01-13 S Prefiled and ordered printed; Offered 01-14-2026 26104820D

Votes

2026-02-05 Reported from Education and Health with substitute (14-Y 0-N) Yea: 14 Nay: 0 2026-02-06 Constitutional reading dispensed (on 1st reading) (39-Y 0-N 0-A) Yea: 39 Nay: 0 2026-02-10 Read third time and passed Senate (40-Y 0-N 0-A) Yea: 40 Nay: 0 2026-02-19 Reported from Health and Human Services (21-Y 0-N) Yea: 21 Nay: 0 2026-02-24 Passed House (98-Y 0-N 0-A) Yea: 98 Nay: 0

Committee Referrals

2026-01-13 S Education and Health 2026-01-30 S Education: Health Professions 2026-02-13 H Health and Human Services 2026-02-16 H Health and Human Services: Health

Bill Text Versions

2026-01-13 Introduced 2026-01-30 Comm Sub 2026-02-06 Comm Sub 2026-02-26 Enrolled Legislative data powered by LegiScan (CC BY 4.0)

Named provisions

Board of Pharmacy; regulation of psilocybin

Get daily alerts for Virginia Legislative Events

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from Virginia.

What's AI-generated?

The plain-English summary, classification, and "what to do next" steps are AI-generated from the original text. Cite the source document, not the AI analysis.

Last updated

Classification

Agency
Virginia
Published
July 1st, 2026
Instrument
Rule
Legal weight
Binding
Stage
Final
Change scope
Substantive
Document ID
2026 Va. Acts Ch. 306

Who this affects

Applies to
Healthcare providers Pharmaceutical companies Government agencies
Industry sector
6211 Healthcare Providers 3254 Pharmaceutical Manufacturing
Activity scope
Controlled substance scheduling Healthcare formulation administration Pharmacy regulation
Threshold
FDA approval of psilocybin formulation for healthcare professional administration in healthcare setting
Geographic scope
Virginia US-VA

Taxonomy

Primary area
Healthcare
Operational domain
Regulatory Affairs
Compliance frameworks
GxP
Topics
Pharmaceuticals Public Health

Get alerts for this source

We'll email you when Virginia Legislative Events publishes new changes.

Optional. Personalizes your daily digest.

Free. Unsubscribe anytime.